Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1Heart Failure 1Cardiotoxicity 1

Interventions

Exercise 8salicylhydroxamic acid 2High-Intensity Interval Training 2Electrocardiography 2Echocardiography 2sacubitril and valsartan sodium hydrate drug combination 1mitoquinone 1epicatechin gallate 1candesartan 1Therapeutics 1Surveys and Questionnaires 1Secondary Prevention 1Restraint, Physical 1Rehabilitation 1Proton Therapy 1Proteins 1Palliative Care 1Methods 1Medical History Taking 1Magnetic Resonance Spectroscopy 1Laser-Doppler Flowmetry 1Ivabradine 1Heart Rate 1Heart Function Tests 1Exercise Test 1Echocardiography, Stress 1Diagnostic Imaging 1Cardiac Rehabilitation 1Blood Pressure 1Blood Cell Count 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Cardiotoxicity × Ivabradine × Clear all
NCT03650205 2019-04-02

IPAC

University of Sao Paulo

Phase NA Unknown
160 enrolled

Heart Failure, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡